Intrahepatic cholangiocarcinoma can hide behind a benign-appearing hepatic cyst
A giant hepatic cyst can look deceptively routine on imaging, yet this case shows how a malignant biliary tumor may be sitting inside the same lesion. In an asymptomatic patient discovered during a physical examination, initial imaging favored a benign giant hepatic cyst. Surgery was pursued on that assumption, and histopathology later confirmed intraductal papillary carcinoma, a rare histologic subtype of intrahepatic cholangiocarcinoma.
The clinical lesson is immediate: cystic appearance does not guarantee cystic biology.
Why this presentation is easy to miss
Primary liver malignancies do not usually announce themselves as simple fluid-filled cysts, which is part of what makes this type of case so treacherous. Intrahepatic cholangiocarcinoma arises from the intrahepatic biliary epithelium, and when it presents in an intraductal papillary form, the tumor architecture may blur the boundary between a neoplasm and a cystic hepatic lesion on imaging. A lesion that seems nonthreatening can therefore mask a malignant epithelial process until tissue is examined directly.
In routine practice, giant hepatic cysts are often approached as benign findings, especially when they are found incidentally and the patient has no symptoms. Yet the coexistence of cholangiocarcinoma with a hepatic cyst is described here as exceedingly rare, which creates a diagnostic blind spot. Radiology can suggest probability, but it cannot provide certainty when the lesion’s internal architecture is atypical or when the tumor is concealed within a larger cystic space.
Imaging favored a cyst, but pathology told a different story
The patient in this report underwent laparoscopic hepatic cystectomy with partial hepatectomy after imaging supported a diagnosis of a giant hepatic cyst. That operative choice reflects standard surgical thinking for a large lesion that appears benign, particularly when size alone raises concern for local effects or future complications. In this case, however, the final diagnosis depended entirely on histopathologic examination.
Histology identified intraductal papillary carcinoma. No surrogate imaging impression can replace that step when a hepatic lesion behaves unusually, and the report illustrates the practical limits of radiologic confidence in cystic liver disease. A thin wall, a large cavity, or an apparently simple configuration can all be misleading if the neoplasm is developing along the biliary epithelium and not presenting as a classic solid mass.
The sharpest problem here is not the operation itself. It is the preoperative assumption that a giant cyst is merely a giant cyst.
The biology behind the masquerade
Papillary biliary tumors are structurally well suited to concealment because they can grow along ducts and line cystic spaces rather than forming a dense, easily recognized mass. In the liver, that pattern can produce a lesion that looks closer to a benign fluid collection than to an invasive cancer. The coexistence of a cystic lesion and a papillary cholangiocarcinoma creates a diagnostic overlap that challenges both imaging interpretation and surgical planning.
For clinicians, the pathology is more than a label. It changes the meaning of an incidental liver lesion entirely. A benign cyst generally leads to observation or limited intervention, while cholangiocarcinoma demands oncologic awareness, complete pathologic assessment, and attention to the possibility of residual or multifocal disease. The malignant diagnosis in this case was not apparent until the specimen was examined after surgery, which is exactly why rare cystic liver lesions deserve careful scrutiny.
Surgical exploration became the diagnostic turning point
Laparoscopic hepatic cystectomy with partial hepatectomy provided the tissue diagnosis that imaging could not. In a case like this, the operating room becomes the place where uncertainty is resolved, but only if the specimen is sent for thorough histologic evaluation. The pathologic result converted what appeared to be a benign hepatic cyst into a malignant biliary neoplasm, and that change has obvious implications for postoperative management and surveillance, even though those downstream steps are not detailed here.
This is the point at which asymptomatic disease can become clinically consequential. A patient without liver-related symptoms still harbored a cancerous lesion, and routine examination was the only reason it came to attention at all. The case therefore reinforces the value of not dismissing incidental hepatic cysts automatically, especially when they are unusually large or anatomically complex.
What this case changes in everyday liver imaging
The report does not suggest that every hepatic cyst should be treated as malignant. It does argue for a lower threshold to question the diagnosis when something about the lesion feels off. Cyst size, internal complexity, or an atypical imaging pattern should prompt a broader differential that includes rare biliary malignancies. Intrahepatic cholangiocarcinoma is uncommon enough in this setting that overcalling malignancy would be harmful, but undercalling it can delay definitive treatment until the tumor has advanced.
That tension is the central clinical challenge. Large hepatic cysts are common enough to normalize, while malignant cystic biliary lesions are rare enough to be overlooked. This case sits directly in that gap, where rarity produces diagnostic inertia and routine assumptions can obscure a dangerous lesion.
For surgeons, radiologists, and hepatobiliary clinicians, the safest approach is disciplined skepticism. A benign-appearing giant hepatic cyst may still conceal intrahepatic cholangiocarcinoma, and only pathology can settle the question when imaging falls short. The case leaves one concrete message: when cystic liver disease behaves unexpectedly, tissue diagnosis should not be an afterthought.